Search

Your search keyword '"Lisdexamfetamine"' showing total 593 results

Search Constraints

Start Over You searched for: Descriptor "Lisdexamfetamine" Remove constraint Descriptor: "Lisdexamfetamine"
593 results on '"Lisdexamfetamine"'

Search Results

1. Can we effectively manage binge eating disorder with pharmacotherapy?

2. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review.

Catalog

Books, media, physical & digital resources

3. LISDEXAMFETAMIN V LÉČBĚ ADHD U DĚTÍ A DOSPÍVAJÍCÍCH.

4. Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA.

5. Attention-deficit/hyperactivity disorder in pregnancy and the postpartum period.

6. Therapeutic Use of Dopamine Enhancers (Stimulants)

8. Switch to Lisdexamfetamine in the Treatment of Attention-Deficit Disorder at a Psychiatric Outpatient Clinic for School-Aged Children: A Danish Cohort Study.

9. Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia

10. Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia.

11. The need for speed? Exploring the risks and benefits of pharmacological treatment for adult ADHD in prisons.

14. Rising prescription stimulant poisoning in Australia: a retrospective case series.

15. Dr Luke Evans ask the Secretary of State for Health and Social Care, what recent discussions he has had with (a) NHS England and (b) drug companies to secure supplies of ADHD medication

16. LISDEXAMFETAMINE (VYVANSE) USE ASSOCIATED WITH BRANCH RETINAL ARTERY OCCLUSION.

17. Rising prescription stimulant poisoning in Australia: a retrospective case series

18. Efficacy of stimulants for preschool attention‐deficit/hyperactivity disorder: A systematic review and meta‐analysis.

19. Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system.

20. In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression.

23. In silico clinical trial evaluating lisdexamfetamine's and methylphenidate's mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients' population.

24. Efficacy of stimulants for preschool attention‐deficit/hyperactivity disorder: A systematic review and meta‐analysis

25. In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression

26. In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population

27. Successful diagnosis of attention deficit hyperactivity disorder in later life of an adult with intellectual disability: A case report.

28. Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review.

29. Causal effects of psychostimulants on neural connectivity: a mechanistic, randomized clinical trial.

30. Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate

31. What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion.

32. Stimulant medications in the management of bulimia nervosa and anorexia nervosa in patients with and without comorbid attention deficit hyperactivity disorder: A systematic review.

33. Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine.

35. Evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression

36. Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine

37. Binge, Purge, and Wander: Navigating Bulimia and Attention Deficit Hyperactivity Disorder (ADHD).

38. Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States.

39. Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate.

40. A Case of Constipation and Gastrointestinal Retention of Lisdexamfetamine Dimesylate Capsules in an 11-Year-Old.

41. Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical Controls.

42. Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States

43. Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate

45. Andrographolide blocks 50-kHz ultrasonic vocalizations, hyperlocomotion and oxidative stress in an animal model of mania.

46. Memory loss induced by lisdexamfetamine in the rat: A behavioral, electrophysiological, and histopathological Study.

47. Assessment of lisdexamfetamine on executive function in rats: A translational cognitive research.

48. Evidence-based therapeutic management of binge-eating disorder

49. Parental ADHD in pregnancy and the postpartum period – A systematic review.

50. Working adeptly to diagnose and treat adult ADHD: Rely on DSM-5 criteria and an appropriate rating scale to assess how an individual's inattention, hyperactivity, and impulsivity interfere with functioning in different settings